Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista do Instituto de Medicina Tropical de São Paulo |
Texto Completo: | https://www.revistas.usp.br/rimtsp/article/view/130557 |
Resumo: | Introduction: The World Health Organization (WHO) recommends one single dose of the Yellow Fever (YF) vaccine based on studies of antibody persistency in healthy adults. We assessed the prevalence and titers of YF virus neutralizing antibodies in previously vaccinated persons aged 60 years, in comparison to younger adults. We also evaluated the correlation between antibody titers and the time since vaccination among participants who received one vaccine dose, and the seropositivity among participants vaccinated prior to or within the past 10 years. Methods: previously vaccinated healthy persons aged 18 years were included. YF virus neutralizing antibody titers were determined by means of the 50% Plaque Reduction Neutralization Test. Results: 46 persons aged 60 years and 48 persons aged 18 to 59 years were enrolled. There was no significant difference in the prevalence of YF virus neutralizing antibodies between the two groups (p = 0.263). However, titers were significantly lower in the elderly (p = 0.022). There was no correlation between YF virus neutralizing antibody titers and the time since vaccination. There was no significant difference in seropositivity among participants vaccinated prior to or within the past 10 years. Conclusions: the clinical relevance of the observed difference in YF virus neutralizing antibody titers between the two groups is not clear. |
id |
IMT-1_13a164603b87ad0bf332b97ef2319156 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/130557 |
network_acronym_str |
IMT-1 |
network_name_str |
Revista do Instituto de Medicina Tropical de São Paulo |
repository_id_str |
|
spelling |
Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adultsElderlyImmunizationNeutralizing antibodySeroprevalenceYellow fever vaccine Introduction: The World Health Organization (WHO) recommends one single dose of the Yellow Fever (YF) vaccine based on studies of antibody persistency in healthy adults. We assessed the prevalence and titers of YF virus neutralizing antibodies in previously vaccinated persons aged 60 years, in comparison to younger adults. We also evaluated the correlation between antibody titers and the time since vaccination among participants who received one vaccine dose, and the seropositivity among participants vaccinated prior to or within the past 10 years. Methods: previously vaccinated healthy persons aged 18 years were included. YF virus neutralizing antibody titers were determined by means of the 50% Plaque Reduction Neutralization Test. Results: 46 persons aged 60 years and 48 persons aged 18 to 59 years were enrolled. There was no significant difference in the prevalence of YF virus neutralizing antibodies between the two groups (p = 0.263). However, titers were significantly lower in the elderly (p = 0.022). There was no correlation between YF virus neutralizing antibody titers and the time since vaccination. There was no significant difference in seropositivity among participants vaccinated prior to or within the past 10 years. Conclusions: the clinical relevance of the observed difference in YF virus neutralizing antibody titers between the two groups is not clear.Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo2017-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/rimtsp/article/view/130557Revista do Instituto de Medicina Tropical de São Paulo; Vol. 59 (2017); e2Revista do Instituto de Medicina Tropical de São Paulo; Vol. 59 (2017); e2Revista do Instituto de Medicina Tropical de São Paulo; v. 59 (2017); e21678-99460036-4665reponame:Revista do Instituto de Medicina Tropical de São Pauloinstname:Instituto de Medicina Tropical (IMT)instacron:IMTenghttps://www.revistas.usp.br/rimtsp/article/view/130557/126915Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Pauloinfo:eu-repo/semantics/openAccessMiyaji, Karina TakesakiAvelino-Silva, Vivian IidaSimões, MarisolFreire, Marcos da SilvaMedeiros, Carlos Roberto deBraga, Patrícia EmiliaNeves, Maria Angélica AcaláLopes, Marta HeloisaKallas, Esper GeorgesSartori, Ana Marli Christovam2018-02-23T18:46:00Zoai:revistas.usp.br:article/130557Revistahttp://www.revistas.usp.br/rimtsp/indexPUBhttps://www.revistas.usp.br/rimtsp/oai||revimtsp@usp.br1678-99460036-4665opendoar:2022-12-13T16:52:37.796175Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT)true |
dc.title.none.fl_str_mv |
Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults |
title |
Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults |
spellingShingle |
Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults Miyaji, Karina Takesaki Elderly Immunization Neutralizing antibody Seroprevalence Yellow fever vaccine |
title_short |
Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults |
title_full |
Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults |
title_fullStr |
Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults |
title_full_unstemmed |
Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults |
title_sort |
Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults |
author |
Miyaji, Karina Takesaki |
author_facet |
Miyaji, Karina Takesaki Avelino-Silva, Vivian Iida Simões, Marisol Freire, Marcos da Silva Medeiros, Carlos Roberto de Braga, Patrícia Emilia Neves, Maria Angélica Acalá Lopes, Marta Heloisa Kallas, Esper Georges Sartori, Ana Marli Christovam |
author_role |
author |
author2 |
Avelino-Silva, Vivian Iida Simões, Marisol Freire, Marcos da Silva Medeiros, Carlos Roberto de Braga, Patrícia Emilia Neves, Maria Angélica Acalá Lopes, Marta Heloisa Kallas, Esper Georges Sartori, Ana Marli Christovam |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Miyaji, Karina Takesaki Avelino-Silva, Vivian Iida Simões, Marisol Freire, Marcos da Silva Medeiros, Carlos Roberto de Braga, Patrícia Emilia Neves, Maria Angélica Acalá Lopes, Marta Heloisa Kallas, Esper Georges Sartori, Ana Marli Christovam |
dc.subject.por.fl_str_mv |
Elderly Immunization Neutralizing antibody Seroprevalence Yellow fever vaccine |
topic |
Elderly Immunization Neutralizing antibody Seroprevalence Yellow fever vaccine |
description |
Introduction: The World Health Organization (WHO) recommends one single dose of the Yellow Fever (YF) vaccine based on studies of antibody persistency in healthy adults. We assessed the prevalence and titers of YF virus neutralizing antibodies in previously vaccinated persons aged 60 years, in comparison to younger adults. We also evaluated the correlation between antibody titers and the time since vaccination among participants who received one vaccine dose, and the seropositivity among participants vaccinated prior to or within the past 10 years. Methods: previously vaccinated healthy persons aged 18 years were included. YF virus neutralizing antibody titers were determined by means of the 50% Plaque Reduction Neutralization Test. Results: 46 persons aged 60 years and 48 persons aged 18 to 59 years were enrolled. There was no significant difference in the prevalence of YF virus neutralizing antibodies between the two groups (p = 0.263). However, titers were significantly lower in the elderly (p = 0.022). There was no correlation between YF virus neutralizing antibody titers and the time since vaccination. There was no significant difference in seropositivity among participants vaccinated prior to or within the past 10 years. Conclusions: the clinical relevance of the observed difference in YF virus neutralizing antibody titers between the two groups is not clear. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/rimtsp/article/view/130557 |
url |
https://www.revistas.usp.br/rimtsp/article/view/130557 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/rimtsp/article/view/130557/126915 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo |
publisher.none.fl_str_mv |
Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo |
dc.source.none.fl_str_mv |
Revista do Instituto de Medicina Tropical de São Paulo; Vol. 59 (2017); e2 Revista do Instituto de Medicina Tropical de São Paulo; Vol. 59 (2017); e2 Revista do Instituto de Medicina Tropical de São Paulo; v. 59 (2017); e2 1678-9946 0036-4665 reponame:Revista do Instituto de Medicina Tropical de São Paulo instname:Instituto de Medicina Tropical (IMT) instacron:IMT |
instname_str |
Instituto de Medicina Tropical (IMT) |
instacron_str |
IMT |
institution |
IMT |
reponame_str |
Revista do Instituto de Medicina Tropical de São Paulo |
collection |
Revista do Instituto de Medicina Tropical de São Paulo |
repository.name.fl_str_mv |
Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT) |
repository.mail.fl_str_mv |
||revimtsp@usp.br |
_version_ |
1798951651628810240 |